You have 9 free searches left this month | for more free features.

Venetoclax

Showing 351 - 375 of 485

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS (MDS) Trial in Worldwide (Azacitidine, Venetoclax)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Tucson, Arizona
  • +36 more
Aug 1, 2022

Relapsed or Refractory Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Venetoclax
  • Cona, Ferrara, Italy
  • +26 more
Jan 3, 2022

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Hangzhou (Azacitidine in Combination With Venetoclax)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Azacitidine in Combination With Venetoclax
  • Hangzhou, Zhejiang, China
    The first Affiliated Hospital of Zhejiang University
Mar 24, 2021

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • La Jolla, California
  • +41 more
Aug 10, 2022

Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast

Terminated
  • Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
  • Phoenix, Arizona
  • +39 more
Jun 21, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL) Trial in Japan (azacitadine, venetoclax,

Completed
  • Non-Hodgkin Lymphoma (NHL)
  • +4 more
  • Nagoya shi, Aichi, Japan
  • +13 more
Jul 29, 2021

Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • Alcalá De Henares, Spain
  • +14 more
May 17, 2021

Lymphoma, Mantle-Cell, Recurrent Lymphoma, Mantle-Cell Trial in United States (ABT-199 and Ibrutinib Combination)

Completed
  • Lymphoma, Mantle-Cell
  • Recurrent Lymphoma, Mantle-Cell
  • ABT-199 and Ibrutinib Combination
  • Duarte, California
  • +3 more
May 22, 2022

Multiple Myeloma Trial in Spain, United Kingdom, United States (Venetoclax, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Venetoclax
  • +2 more
  • Columbus, Georgia
  • +10 more
Jun 9, 2021

Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +11 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 29, 2021

Follicular Lymphoma Trial in Houston, Melbourne, Nedlands (Obinutuzumab, Venetoclax, Lenalidomide)

Recruiting
  • Follicular Lymphoma
  • Houston, Texas
  • +2 more
Nov 30, 2020

Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

Recruiting
  • Previously Untreated Acute Myeloid Leukemia
  • Samalizumab (BAML-16-001-S1)
  • +32 more
  • Phoenix, Arizona
  • +18 more
Oct 17, 2022

Multiple Myeloma Trial in Worldwide (Cobimetinib, Venetoclax, Atezolizumab)

Completed
  • Multiple Myeloma
  • Brno, Czechia
  • +27 more
Aug 5, 2021

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Venetoclax)

Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +39 more
Mar 2, 2022

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Venetoclax
  • Trieste, Italy
    SC Ematologia Ospedale Maggiore
Sep 14, 2020

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +3 more
  • Little Rock, Arkansas
  • +82 more
Jan 17, 2023

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +9 more
Jan 3, 2023

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Aurora, Colorado
  • +55 more
Jan 30, 2023

Acute Myeloid Leukemia Trial in Worldwide (Azacitidine, IMGN632, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +19 more
May 25, 2021

Lymphoma, B-Cell Trial in Vancouver, Toronto, Montreal (Venetoclax, RiTUXimab Injection, Rituximab SC)

Recruiting
  • Lymphoma, B-Cell
  • Venetoclax
  • +5 more
  • Vancouver, British Columbia, Canada
  • +2 more
Jan 24, 2022

AL Amyloidosis Trial in Boston (Venetoclax, Dexamethasone)

Terminated
  • AL Amyloidosis
  • Boston, Massachusetts
    Tufts Medical Center
Aug 19, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Phoenix, Arizona
  • +116 more
Jun 27, 2022

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022